Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effectiveness of stepwise intravenous carbetocin in elective cesarean delivery
TCTR20231009002Phase 2Completed
- Sponsor
- Routine to Research Unit, Siriraj Hospital
- Start
- Jan 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of carbetocin in postpartum hemorrhage (PPH), uterine atony, sponsored by Routine to Research Unit, Siriraj Hospital. Started Jan 2023; status: completed.
02
Drugs
carbetocin
03
Conditions
postpartum hemorrhage (PPH)uterine atony
Beyond the preview
Go deeper on TCTR20231009002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20231009002.